Reality check: should we use vancomycin for the prophylaxis of intravascular catheter-associated infections?

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
L A GrohskopfD A Goldmann

Abstract

The use of intravascular catheters is associated with increased risk of bloodstream infections, principally caused by coagulase-negative staphylococci. This "Reality Check" session, held at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections, focused on the question of whether, and in what manner, vancomycin should be used for the prophylaxis of these infections

References

Nov 1, 1992·JPEN. Journal of Parenteral and Enteral Nutrition·Y InoueA Okada
Oct 8, 1992·The New England Journal of Medicine·D K CobbB M Farr
Sep 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C SchwartzK Powell
May 25, 1994·JAMA : the Journal of the American Medical Association·D PittetR P Wenzel
Mar 12, 1999·Annual Review of Medicine·J Huebner, D A Goldmann
Feb 26, 2000·Annals of Internal Medicine·L A Mermel
Apr 15, 2000·Annals of Internal Medicine·R J SherertzE F Haponik

❮ Previous
Next ❯

Citations

Nov 28, 2001·Current Infectious Disease Reports·Nasia SafdarDennis G. Maki
Mar 12, 2002·The Journal of Hospital Infection·D NathwaniH Borland
Jan 3, 2006·JPEN. Journal of Parenteral and Enteral Nutrition·Marcia Ryder
Nov 28, 2001·Hematology·G R DonowitzK V Rolston

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.